The Multidimensional Pathogenesis of Susceptibility to Depression in Sjögren’s Syndrome: An Integrated Approach from Immune–Inflammatory to Psychosocial Factors
Open Access
- 9 November 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10038
Abstract
Sjögren’s syndrome is a chronic systemic autoimmune disease with primary (pSS) and secondary forms. Epidemiological evidence suggests a higher prevalence of depressive symptoms and depression in pSS than in the general population, indicating possible disease-specific susceptibility. The underlying mechanisms remain unclear, limiting early identification and targeted intervention. This narrative review examines five domains of depression susceptibility in pSS: inflammatory pathways, neuroendocrine regulation, the gut–brain axis, medication effects, and psychosocial factors. Interleukin-6, tumor necrosis factor-α, and interferon-α may contribute by activating the indoleamine 2,3-dioxygenase–kynurenine pathway, downregulating brain-derived neurotrophic factor, and inhibiting hippocampal neurogenesis. Hypothalamic–pituitary–adrenal axis dysfunction may provide a neuroendocrine link, whereas gut microbial imbalance may affect emotional regulation through immune and neural signaling. Glucocorticoids, hydroxychloroquine, and calcineurin inhibitors may increase neuropsychiatric risk through multiple pathways. Somatic symptoms and social stress may reinforce a psychosocial vicious cycle. Much of the mechanistic evidence comes from major depressive disorder, animal models, or in vitro studies; causality has not been established in pSS. The proposed multidimensional model is hypothetical and offers a framework for early screening and targeted intervention in pSS with depression.Keywords
This publication has 126 references indexed in Scilit:
- Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic reviewNeuroprotection, 2025
- Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysisEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid ArthritisArthritis Care & Research, 2019
- Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trialRheumatology International, 2019
- How stress contributes to autoimmunity—lessons from Sjögren's syndromeFEBS Letters, 2017
- Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlationsBrain and Behavior, 2016
- Association of Hippocampal Atrophy With Cerebrospinal Fluid Antibodies Against the NR2 Subtype of the N‐Methyl‐D‐Aspartate Receptor in Patients With Systemic Lupus Erythematosus and Patients With Primary Sjögren's SyndromeArthritis & Rheumatology, 2014
- Memory Dysfunction in Primary Sjögren's Syndrome Is Associated With Anti‐NR2 AntibodiesArthritis & Rheumatism, 2013
- Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathwayPsychopharmacology, 2012
- Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndromeArthritis Care & Research, 2008